Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/08/1996WO1996023878A1 Human immunodeficiency virus transcription inhibitors and methods of their use
08/08/1996WO1996023876A1 Expression system and method for inhibiting replication of human immunodeficiency virus (hiv)
08/08/1996WO1996023875A1 Purified vibriolysin
08/08/1996WO1996023869A1 RECOMBINANT α-GALACTOSIDASE ENZYME
08/08/1996WO1996023866A1 Saccular collagen and compositions and methods for making and using the same
08/08/1996WO1996023816A1 Radiolabelled proteins
08/08/1996WO1996023814A1 Chimeric receptor molecules for delivery of co-stimulatory signals
08/08/1996WO1996023813A1 Peptides and compounds that bind to sh2 domains
08/08/1996WO1996023812A1 Proline derivatives useful as inhibitors of human leukocyte elastase
08/08/1996WO1996023809A1 Neuropeptide y receptor
08/08/1996WO1996023523A1 Novel hemostatic composition
08/08/1996WO1996023522A1 Treatment of diabetic neuropathy
08/08/1996WO1996023521A1 Il-12 inhibition of b1 cell activity
08/08/1996WO1996023520A1 Anti-obesity proteins
08/08/1996WO1996023519A1 Anti-obesity proteins
08/08/1996WO1996023518A1 Anti-obesity proteins
08/08/1996WO1996023517A1 Anti-obesity proteins
08/08/1996WO1996023516A1 Anti-obesity proteins
08/08/1996WO1996023515A1 Anti-obesity proteins
08/08/1996WO1996023514A1 Anti-obesity proteins
08/08/1996WO1996023513A1 Anti-obesity proteins
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023508A1 Synthetic oligonucleotides which mimic telomeric sequences
08/08/1996WO1996023487A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996WO1996015816A3 Stable n-terminally linked dtpa:protein compositions and methods
08/08/1996WO1996015244A3 Sensory and motor neuron derived factor (smdf)
08/08/1996WO1996015242A3 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor
08/08/1996WO1996013610A3 Methods and reagents for the identification and regulation of senescence-related genes
08/08/1996WO1996012738A3 Pepstatin-derivatives for the treatment and detection of fungal infections
08/08/1996DE19521046C1 DNA encoding DNase and related vectors, host cells and antibodies
08/08/1996DE19504755A1 New antibodies against HIV antigens
08/08/1996DE19503338A1 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung Dosage form for the delivery of collagenase to wounds and methods for their preparation
08/08/1996DE19503082A1 Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen Subject and methods of preferred transient expression and possible translation of specific RNA in the cytoplasmic region of higher eukaryotic cells
08/08/1996DE19501378A1 Enzymatic treatment and prophylaxis of heart and circulation problems
08/08/1996CA2221634A1 Chimeric receptors for regulating cellular proliferation and effector function
08/08/1996CA2221629A1 Chimeric receptor molecules for delivery of co-stimulatory signals
08/08/1996CA2212225A1 Neuropeptide y receptor
08/08/1996CA2212059A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
08/08/1996CA2212006A1 Novel c-mpl ligands
08/08/1996CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof
08/08/1996CA2211877A1 Human immunodeficiency virus transcription inhibitors and methods of their use
08/08/1996CA2211801A1 Anti-obesity proteins
08/08/1996CA2211795A1 Anti-obesity proteins
08/08/1996CA2211784A1 Anti-obesity proteins
08/08/1996CA2211713A1 Human peroxisome proliferator activated receptors
08/08/1996CA2211684A1 Anti-obesity proteins
08/08/1996CA2211664A1 Anti-obesity proteins
08/08/1996CA2211662A1 Anti-obesity proteins
08/08/1996CA2211659A1 Anti-obesity proteins
08/08/1996CA2211656A1 Anti-obesity proteins
08/08/1996CA2211450A1 Treatment of diabetic neuropathy
08/08/1996CA2211417A1 Recombinant .alpha.-galactosidase enzyme
08/08/1996CA2211099A1 Modified ligands for receptor tyrosine kinases
08/08/1996CA2210928A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996CA2209675A1 Proline derivatives useful as inhibitors of human leukocyte elastase
08/08/1996CA2186943A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/07/1996EP0725145A1 Method of modifying protein
08/07/1996EP0725141A1 Method of controlled genetic transformation of an animal mammary gland and a device for introducing genetic material into the mammary duct of an animal mammary gland
08/07/1996EP0725136A1 Nucleotide and peptide sequences of the USHER-lB gene diagnostic and therapeutic applications
08/07/1996EP0725135A1 Gene that codes for polypeptide having ability to support pre-b cell proliferation
08/07/1996EP0725081A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA
08/07/1996EP0725080A1 Novel protein and process for producing the same
08/07/1996EP0725079A1 Anti-obesity proteins
08/07/1996EP0725078A1 Anti-obesity proteins
08/07/1996EP0725077A1 Novel glycoproteins, process for preparation thereof, and pharmaceutical composition
08/07/1996EP0725075A1 Peptide derivatives comprising a phosphinic acid moiety as inhibitors of zinc depending endopeptidase 24-25
08/07/1996EP0724884A1 Side effect inhibitor for cancer therapy
08/07/1996EP0724882A1 Novel anti-hiv drug
08/07/1996EP0724644A1 Dna encoding 1,3-beta-d glucan synthase subunits
08/07/1996EP0724638A1 Avian interferon genes, novel recombinant dna and proteins
08/07/1996EP0724637A1 Corticotropin-releasing factor 2 receptors
08/07/1996EP0724635A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis
08/07/1996EP0724633A1 Recombinant transferrins, transferrin half-molecules and mutants thereof
08/07/1996EP0724632A1 Stem cell proliferation factor
08/07/1996EP0724602A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS
08/07/1996EP0724600A1 Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained
08/07/1996EP0724599A1 Platelet-derived growth factor analogues
08/07/1996EP0724598A1 Growth factor heterodimers
08/07/1996EP0724597A1 Ks-laminin and methods of use
08/07/1996EP0724596A1 Method and means for producing plasmaproteinase inhibitor-binding proteins
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724593A1 Coiled-coil stem loop templates
08/07/1996EP0724590A1 $i(PLASMODIUM FALCIPARUM) RIBONUCLEOTIDE REDUCTASE, ENCODING DNA, AND INHIBITORS
08/07/1996EP0724588A1 Drug binding protein
08/07/1996EP0724561A1 Calcium receptor-active arylalkyl amines
08/07/1996EP0724459A1 Formulations for delivery of osteogenic proteins
08/07/1996EP0724456A1 Antibodies to cd40
08/07/1996EP0724453A1 The cloning of duffy blood group antigen
08/07/1996EP0724452A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND $g(a)-TOCOPHEROL
08/07/1996EP0724446A1 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
08/07/1996EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
08/07/1996EP0724433A1 Method for preparing microspheres comprising a fluidized bed drying step
08/07/1996EP0527813B1 T-CEL LYMPHOMA cDNA CLONES
08/07/1996EP0507825B1 Antitumoral composition based on polypeptides having human interleukin 2 activity
08/07/1996CN1128531A Therapeutic compound-fatty acid conjugates
08/07/1996CN1128495A Pharmaceutical compositions for hardly soluble active substances
08/07/1996CN1128271A Preparation of stable zinc insulin analog crystals
08/07/1996CN1128168A The use of vWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
08/07/1996CN1032471C Preparation for stable hemoglobin
1 ... 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 ... 3163